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INTRODUCTION 
Tobacco is the leading cause of preventable 
mortality1-3 and one of the biggest threats to public 
health. It kills at least 8 million people a year, of 
which more than 7 million are direct consumers and 
around 1.2 million are non-smokers exposed to the 
smoke of others. Unfortunately, reducing smoking 
consumption is not enough. In those smokers who 
reduce their consumption by more than 50%, the risk 
of mortality from all causes is similar to those who 
continue smoking4. In addition, despite worldwide 
awareness campaigns about the risks of smoking, not 
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ABSTRACT
INTRODUCTION Tobacco is the leading cause of preventable mortality. 
The use of mobile phones has grown exponentially, becoming a 
powerful tool to be used in health care.
METHODS In order to assess the effectiveness of mobile phones to quit 
smoking, we have carried out a systematic review and meta-analysis 
of randomized clinical trials evaluating interventions based on mobile 
applications for smartphones, that were not a smaller version of the 
same application, against other types of therapy. To address this, a 
bibliographic search was carried out in MEDLINE, EMBASE and 
COCHRANE LIBRARY. To obtain the combined effect, the relative 
risk and the 95% confidence interval were used. A heterogeneity and 
sensitivity analysis were also conducted.
RESULTS A total of nine studies were identified, but five were excluded. 
Qualitative review was performed with four selected studies, but 
quantitative analysis was carried out for only three, given the 
impossibility of calculating the RR in one of the studies. After 
combining the results, an RR of 0.901 (95% CI: 0.57-1.423) was 
calculated comparing the effectiveness of mobile applications versus 
others type of interventions. This measure was robust, as shown by 
the sensitivity analysis.
CONCLUSIONS According to the results, it cannot be concluded that 
apps are effective for quitting tobacco. There are very few clinical 
trials published evaluating the effectiveness of mobile applications 
compared to other alternatives. Several clinical trials are still in 
progress, therefore their results have not been included in the 
present meta-analysis.
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many people understand the specific health risks of 
inhalation. For example, a study conducted in China 
in 2009 revealed that only 38% of smokers knew that 
tobacco causes coronary heart disease, and only 27% 
knew that it provokes strokes5. 
Quitting smoking can be a particular challenge. 
According to a study, over 30 attempts to quit may 
be necessary to quit smoking6. Nicotine dependence 
is a complex disorder. In fact, it has been observed 
that the greater the nicotine dependence, the lower 
the probability of success7, motivation being one of 
the main factors to quit the habit8. As a consequence, 
development and optimization of behavioral 
strategies to quit smoking are gaining relevance.
Behavioral support strategies increase dropout 
rates9. In the last few years, a wide range of platforms 
and strategies of behavioral therapy based on 
clinical-patient health advice have been developed 
including the telephone line, text messaging, web-
based interventions and mobile applications that 
can be used independently or as an adjuvant tool10. 
Whittaker et al.11 published in 2016 a meta-analysis 
of interventions based on mobile telephones to quit 
smoking that included all the tools described above 
except mobile applications (apps). Results showed a 
beneficial effect compared to usual clinical practice 
(RR=1.67; 95% CI: 1.46–1.90)11. Other research 
studies have found similar results12-14. On the other 
hand, applications to quit smoking have also been 
developed through mobile phones, though data 
on this matter are still limited15. In fact, data on 
the quality of content and the effectiveness of the 
approach are still scarce16-18. For instance, in a recent 
systematic review, although authors identified almost 
50 mobile applications for smoking cessation, only 
4% had suitable scientific support19.
Since the launch of mobile networks in the 
1980s, the use of mobile phones has grown 
exponentially. The International Communications 
Union estimated that by the end of 2015 there 
would be about 7 billion mobile phones worldwide, 
that is a penetration of 97%, making these devices 
increasingly useful for healthcare20. Indeed, 
numerous applications are now available to 
provide help with many important tasks including 
information and time management, maintenance 
and access to sanitary records, communications and 
consulting, reference and information gathering, 
patient management and monitoring, clinical 
decision making and medical education and 
training21-23. 
The use of health applications among mobile 
phone users has also increased significantly. In 
a survey conducted in the United States, it was 
concluded that a little over half (58.23%) of mobile 
phone users had downloaded a health-related mobile 
app. These results were dependent on several factors 
such as age and educational level, with the age of app 
users being lower (OR=0.97; 95% CI: 0.96–0.98) 
than that of non-users, and the higher educational 
level related to higher app usage (OR=1.12; 95% CI: 
1.01–1.24)24. However, in another study evaluating 
the characteristics of users of mobile applications 
to quit smoking, it was found that demographic 
characteristics such as age and education level were 
not associated with the attitude towards the use of a 
tobacco cessation application, but rather depended 
on characteristics related to the content of the 
application instead of the general characteristics of 
the users25.
Assuming the wide penetration of mobile 
telephones and the use of health applications by 
the population (3.2 billion downloads in 2016)26, 
we decided to explore whether the use of smoking 
cessation applications is supported by scientific 
evidence. To address this issue, a systematic 
review and meta-analysis of randomized clinical 
trials evaluating interventions based on mobile 
applications to quit smoking was carried out.
METHODS
We conducted a systematic review and meta-analysis 
of clinical trials evaluating the effectiveness of 
applications for smartphones to quit smoking against 
other types of therapy that were not a smaller version 
of the same application, or other different applications 
(SMS, computer or tablet websites, clinical practice, 
health advice on smoking). For this purpose, we 
performed, in December 2019, first a bibliographic 
search, in MEDLINE, EMBASE and COCHRANE 
LIBRARY databases with the following search string: 
(‘Mobile Applications’ [Mesh]) AND (‘Smoking 
Cessation’ [Mesh]), filtering by type of study 
including Clinical Trial, Meta-Analysis, Randomized 
Controlled Trial, and Systematic Review. No language 
restriction was applied. Given the lack of studies, we 
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also searched in google and other web browsers, and 
searched for unpublished studies in the platform 
clinicaltrials.gov.
The studies could be masked and not masked. The 
main variable evaluated was smoking abstinence. 
The follow-up period was between 3 and 6 months.
A qualitative and quantitative analysis was 
performed with selected studies. In the qualitative 
analysis, risk of bias assessment was carried out 
(random sequence generation of allocation, 
concealment of allocation, blinding of participants 
and staff, blinding of outcome assessors, incomplete 
outcome data, and selective reporting of results). In 
the quantitative analysis the risk of publication bias, 
heterogeneity test, estimation of pooled measure and 
a sensitivity analysis were performed.
Quality assessment of clinical trials
An evaluation of the risk of bias of the different studies 
included was carried out using the tool developed 
by the Cochrane group, which is a domain-based 
evaluation (random sequence generation of allocation, 
concealment of allocation, blinding of participants 
and staff, blinding of outcome assessors, incomplete 
outcome data, selective reporting of results, other 
biases)27. Each domain is classified as high, medium or 
low risk of bias. All studies were included, regardless 
of the risk of each27.
Heterogeneity analysis
A heterogeneity analysis was performed to evaluate 
the variability among the studies included in the 
meta-analysis. To address this, the statistical test Q 
of DerSimonian and Laird28 was used. Due to low 
statistical power, the confidence level was set at 
90%29. The Q test was completed with the graphics of 
Galbraith30 and L’Abbé et al.31. The I2 index was also 
calculated from the equation:
I2 = (Q – df)/Q ×100% 
where Q is the Cochran homogeneity test statistic and 
df is the degrees of freedom (number of trials minus 
1). The heterogeneity was considered important if I2 
>50%32.
Publication bias
Possible publication bias was assessed using the Egger 
and Begg statistic and two graphs (Funnel plot and 
Egger) were constructed. The confidence level for 
both tests was set at 95%.
Pooled measured estimation
Tobacco cessation was measured by the variable 30 days 
(30PP) or 7 days point prevalence (7PP) at 6 months 
from the beginning. To obtain the combined effect for 
all the studies included in the meta-analysis, the relative 
risk (RR) and the 95% confidence interval were used.
Sensitivity analysis
The influence of each of the studies on the overall 
estimation of the effect and, therefore, the robustness 
of the final measurement, was studied. To address this, 
the meta-analysis was repeated as many times as the 
number of the selected studies, skipping one of the 
studies each time while combining the remaining 
ones.
RESULTS
A total of nine studies were identified for this 
meta-analysis. After a more thorough review of the 
identified studies by the research team, five were 
discarded because they did not meet the eligibility 
criteria. In fact, four of them compared different 
versions of the same application (one more extensive 
version and another much smaller), and 1 was not 
a clinical trial but a cross-sectional study evaluating 
the characteristics of users of web-based programs or 
websites for mobiles (Figure 1). The characteristics 
of the four studies33-36 selected are summarized in 
Table 1. Qualitative analysis was performed with four 
studies, but the quantitative analysis was only carried 
out with the studies of Buller et al.35, Danaher al.34, 
and Baskerville et al.36, given the impossibility of 
calculating the RR for the study by Peiris et al.33.
Risk assessment of bias
The risk assessment of bias of each study is analyzed 
in Figure 2. The main characteristics of each study 
are now described.
In the study of Peiris et al.33, 49 current Aboriginal 
smokers (aged >16 years), who were willing to make 
a quit attempt in the next month, and with access 
to an iPhone or Android smartphone participated 
in the clinical trial. The intervention consisted of 
a personalized profile and quit plan, text and in-
app motivational message. The comparator was 
usual cessation support services. Randomization 
Review Paper Tobacco Prevention & Cessation
4Tob. Prev. Cessation 2020;6(November):62
https://doi.org/10.18332/tpc/127770
was conducted through a central computer-based 
randomization service; therefore, we could think that 
the randomization sequence was kept hidden until 
the moment of the assignment. Outcome analysis and 
data collection were conducted blinded to treatment 
allocation, but authors do not mention anything 
about patients. The primary outcome was self-
reported continuous smoking abstinence verified 
by carbon monoxide breath testing at 6 months. 
Statistical analysis was not carried out by intention 
to treat. Three people from intervention group were 
lost in the follow-up.
In the study of Danaher et al.34, 1271 smokers 
(aged ≥18 years) who wanted to quit were randomly 
assigned to: 1) MobileQuit (designed for its use 
in mobile devices), or 2) QuitOnline (designed 
for non-mobile desktop or tablet computers). 
Inclusion criteria were smokers who consumed 
≥5 cigarettes/day in the previous 6 months and 
those who wanted to quit smoking in next 14 days. 
Figure 1 

















From: Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA 
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Figure 1. PRISMA flow diagram
From: Moher D, Liberati A, Tetzlaff J, Altman DG,  The PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLoS Med. 
2009;6(6):e1000097. doi:10.1371/journal.pmed.1000097. Prisma statement check list included in Supplementary file.
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Participants completed an internet-based registration 
procedure before being assigned to a condition, via 
a computer-generated randomization. We could 
expect that the sequence of concealment was kept 
hidden until assignment moment. Authors do not 
mention anything about blinding of participants, 
researchers, and person responsible for statistical 
analysis. Statistical analysis was carried out both by 
intention to treat (participants who did not complete 
their assessments were considered to be smokers) 
and by complete cases. The primary variable was 7 
days point prevalence at follow-up at 3 and 6 months. 
The protocol was published in clinicaltrials.org with 
number NCT01952236.
The study of Buller et al.35 was a clinical trial that 
included 102 adult smokers aged 18–30 years. Half 
were assigned to REQMobile, and the other to onQ, 
using an online randomization program. Patients 
Table 1. Studies reviewed
Authors Title Sample Intervention and comparator Main variables 
and follow-up
Results
Buller et al.35 Randomized Trial of 
a Smartphone Mobile 
Application Compared 
to Text Messaging 
to Support Smoking 
Cessation 
Young adult smokers 
aged 18–30 years 
(n=102)
Of the patients, 58-
66% were planning 
to quit smoking
This study compares a mobile 
application (REQ-Mobile) 
(n=51) with text messaging 
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smokers (aged >16 
years; mean ± SD 
42 ± 14) years), who 
were willing to make 
a quit attempt in the 
next month
The majority of 
patients were smokers 
of <20 cigarettes/day
The intervention was a 
multifaceted Android or iOS 
app comprising a personalized 
profile and quit plan, text and 
in-app motivational messages 
(n=22). The comparator 
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Danaher et al.34 Outcomes and 
Device Usage for 
fully automated 
internet interventions 
designed for a 
smartphone or 
personal computer: 




1271 smokers (aged 
≥18 years; mean ± 
SD 42.9 (12.3) years) 
who wanted to quit 
in next 14 days
Patients were smokers 
of ≥5 cigarettes/
day in the previous 6 
months
Patients were randomly 
assigned to MobileQuit  
(n=633) (designed for use in 
mobile phones) or QuitOnline 
(n=638) (designed for non-
mobile desktop or tablet 
computers)
Point prevalence 
self-reported at 3 














Baskerville et al.36 Effect of a Mobile 
Phone Intervention 
on Quitting Smoking 




1599 young adult 
smokers (aged 19–29 
years) intending to 
quit smoking in the 
next 30 days
Patients were randomized 
to one of two groups: 
an evidence-informed 
smartphone app for smoking 
cessation, Crush the Crave 
(CTC) (n=820) and the control 
group, an evidence-informed 
self-help guide, On the Road 
to Quitting (OnRQ) (N=779)
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continuous 
abstinence at 6 
months follow-up 
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were registered into the study web site without 
revealing them to the investigators, but authors do 
not mention anything about patients. The effect of 
treatment was analyzed by intention to treat analysis. 
Patients lost to follow-up were considered as smokers 
for statistical analysis. In addition, the protocol of this 
clinical trial was not found. All smokers were invited 
by e-mail to complete follow-up questionnaires 
online at 6 and 12 weeks to collect self-reported 
smoking status. Quitting tobacco was measured at 6 
and 12 weeks as 30-day point-prevalence (30 PP), 
defined as not smoking in the past 30 days.
In the study of Baskerville et al.36, 1520 
participants aged 19–29 years were eligible if they 
were considering quitting smoking in the next 30 
days. Those referred to the study by a friend or a 
family member already participating in the trial, 
were excluded to avoid possible contamination bias. 
Patients that met inclusion criteria were randomly 
allocated to either the control or intervention arm, 
receiving a computer-generated email confirming 
registration. Researchers, data collectors, and 
participants, were blinded to the group assignments. 
The protocol was available before the study started, 
as it was registered in clinicaltrials.org with number 
CT01983150. The statistical analysis was carried out 
by intention to treat. Follow-up was conducted at 3 
and 6 months, post-randomization. Quitting tobacco 
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Figure 2. Risk of bias Figure 3. Galbraith graphic
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was measured with the self-reported 30-day point-
prevalence abstinence (PPA) from smoking at 3 and 
6 months.
Heterogeneity analysis
According to the results of the DerSimonian and 
Laird11 test, there is statistical heterogeneity among 
the studies included in the meta-analysis (P<0.05). 
Similar results can be drawn from the graphs of 
Galbraith (Figure 3) and L’Abbé (Figure 4). In the 
former, we can observe that 2 studies are outside 
the confidence bands, while in the latter, we observe 
that points were not over a straight line. Despite the 
heterogeneity between studies, all were maintained 
in the analysis. I2 index was 76.41%.
Publication bias
The p-value of the statistical tests performed was 
greater than 0.05, suggesting a lack of publication 
bias. When analyzing the Funnel Plot and Egger 
graphs (Supplementary file, Figures S1 and S2), we 
realized that results do not follow the statistical tests. 
Thus, the lack of bias cannot be assumed.
Estimation of pooled measurement
The results of the studies included in the meta-
analysis have been combined using a random effects 
model given the existence of heterogeneity. After 
combining the results, a total RR of 0.901 (95% CI: 
0.57-1.423) was estimated (Table 2).
Sensitivity analysis
The study with the greatest influence on the meta-
analysis was that of  Danaher et al.34. When this study 
was deleted, and the meta-analysis was repeated, the 
greatest variation in the estimates of the overall effect 
was obtained. The estimated RR decreased since a 
study with a beneficial effect of the intervention 
to be evaluated was suppressed. The sensitivity 
analysis showed that the measurement is robust as 
the direction of the effect does not change and the 
magnitude of the effect does it minimally (Table 3).
Table 2. Comparison of smartphone app versus other intervention (routine practice, text messaging, app for 
computer or tablet) Table 2. Comparison of Smartphone app versus other intervention (routine practice, text messaging, app for computer or tablet)  
 
                                               
 Risk Ratio,        Weight          Risk Ratio, 
           M-H, Random, CI (95%)                   M-H, Random, CI (95%) 
Study(author, year)             App intervention       Control group 




         9/51         16/51                                                                                21.65%                    0.563 (0,274-1,154] 
                     
  0/22         0/24                -                  Not estimated 
 
          156/633         123/638                               42.36%      1.278[1.037-1.576] 
 
    50/820                60/779              35.98%      0.792[0.551-1.137] 
 
              1526         1492               100%       0.901 [0.57-1.423] 
 
 
Buller at al.352014 
 
Peiris et al.33 2019 
 
Danaher et al.34 2019 
 
Baskerville et al.36 2018 
 
Total 95% CI 
 
 
       0.2   0.4    0.6    0.8     1    1.2    1.4    1.6   1.8 
   
  
Total  events: 215 smartphones app, 199 others interventions. 
Heterogeneity: Chi2=   8.4782; p=0.0144. 
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DISCUSSION
After combining the results of the studies included 
in the meta-analysis, no statistically significant 
differences are observed between the effectiveness 
of the app as a tool to quit smoking and the rest 
of the therapeutic options evaluated.  Relative risk 
for smoking cessation using a mobile application 
for smartphones versus other type of interventions 
was 0.901 (95% CI: 0.57-1.423). Studies have been 
combined using a random effects model given the 
absence of homogeneity among the included studies. 
Strengths and limitations
There are several limitations to the study. First, 
the heterogeneity is not only statistical but also 
clinical, since the populations of the included 
studies are different from each other. Furthermore, 
the interventions and follow-up periods were not 
the same for all studies. Indeed, Buller et al.35 did 
a maximum follow-up of 12 weeks, while in the 
remaining studies it was 6 months. In relation to the 
main variable, Danaher et al.34 measured the 7 days 
point prevalence whereas the remaining studies35,36 
evaluated the 30 days point-prevalence abstinence. 
However, this does not affect our results, because 
those who have smoked in the past 30 days have also 
smoked in the past 7 days. 
Despite the limitations, the present meta-analysis 
study has several important strengths. First, an 
analysis of the risk of bias of the four studies 
was carried out, showing that the risk of bias in 
most domains is not high. Second, an analysis of 
publication bias was performed, detecting that there 
is, indeed, a risk of publication bias, due to the recent 
boom of smartphone applications. Accordingly, many 
ongoing studies will provide results and conclusions 
within 2–3 years37-40 and a new meta-analysis study 
will be welcome. Third, the sensitivity analysis 
showed the robustness of the measurement with 
the available data, with no significant changes in 
the magnitude of the combined measurement when 
repeating the meta-analysis by deleting a study 
each time. Fourth, another meta-analysis evaluating 
the effectiveness of the use of a mobile application 
compared to other alternatives has not been found 
in the literature. The only exception is the study of 
Wittaker et al.41. However, these authors performed 
different meta-analysis depending on the type of 
intervention while our objective was to compare 
the effectiveness of the use of a mobile application 
against any existing intervention to quit smoking.
Future directions
The internet has revolutionized the computer 
and communications world. Indeed, new forms of 
technology have been generated in almost all aspects 
of life42. New mobile devices have appeared on the 
market. As a consequence, the number of downloads 
increased in parallel with the number of mobile phone 
users. For example, in Spain, it is estimated that 3.8 
million applications are downloaded every day. In fact, 
each smartphone has an average of 39 applications43. 
Table 3.  Comparison of Smartphone app versus other intervention. Sensitivity analysis.  
 
                                               
 Risk Ratio,        Weight          Risk Ratio, 
           M-H, Random, CI (95%)                   M-H, Random, CI (95%) 




        2870                        14.38  1.030 (0.646-1.644) 
         
        1701                  -17.98                 0.739 (0.535-1.021) 
 1 
             1373                        1.48   0.914  (0.414-2.016) 
         
  
          1525                 
 
                                                                                         0.901  (0.57-1.423) 
 
 
Buller at al.352014 
 
Danaher et al.34 2019
  




Total 95% CI 
 
       0.2   0.4    0.6    0.8     1    1.2    1.4    1.6   1.8   2 
   
 
Table 3. Comparison of smartphone app versus other intervention: Sensitivity analysis
Table 2. Comparison of smartphone app versus other intervention (routine practice, text messaging app for computer or tablet)  
 
                                               
 Risk Ratio,                   
           M-H, Random, 95% CI                  
Study (author, year)            App intervention       Control group               Weight  Risk Ratio, 




        9/51          16/51                                                                            21.715%         0.563 (0.274–1.539) 
         
0/22         0/24           0/22          -          Not estimated 
 
      156/633         123/638                               40.109%     1.278 (1.037–1.576) 
 
   50/820                60/779                38.176%     0.746 (0.570–0.975) 
 

















       0.2   0.4    0.6    0.8     1    1.2    1.4    1.6   1.8 
   
 
Buller at al.35, 2013 
 
Peiris et al.33, 2019 
 
Danaher et al.34,  2015 
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We are facing a global new revolution in medicine. 
Almost 90% of the world’s population could benefit 
from the opportunities that mobile technologies 
represent at a relatively low cost44. A total of 36% of 
all smartphone owners have mHealth apps on their 
devices. Interestingly, among those using apps, 
60% use mHealth apps in achieving health behavior 
goals45.
CONCLUSIONS
According to the results presented, we are not able 
to claim that apps are effective for quitting tobacco. 
As the boom in mobile applications has been very 
recent, there are very few clinical trials that evaluate 
their effectiveness against other types of smoking 
cessation interventions. Even though some studies 
with protocols of clinical trials have been published 
to evaluate the effectiveness of mobile applications 
compared to other alternatives36-39, the trials are still 
in progress, and therefore the results have not been 
included in the meta-analysis. In addition, as the 
adherence to smoking cessation treatment guidelines 
is generally low, this may potentially have a negative 
impact on the effectiveness of apps46. On the other 
hand, and focusing on the usefulness of health app 
use, there are several patient characteristics that 
make the difference. Age and education level are 
significantly related to mobile health app use. The 
young and more highly educated are more likely to 
use them. Although gender is not associated with 
general mobile health app use, men are more likely 
to use fitness apps than women, and women are more 
likely to use nutrition, self-care, and reproductive 
health apps47. Last, but not least, as it is well known 
that changes promoted by health advice do not last 
over time (no more than six months), it would be 
convenient to design clinical trials with follow-up 
periods longer than 6 months, at least one year, 
to have a more suitable evaluation of the app47. Is 
investing in promoting the use of mobile applications 
justified, or do we have to continue using tools that 
have showed effectiveness until now7. In summary, it 
is necessary to go deeper into the characteristics of 
each app and into the features of potential users in 
order to try to maximize adherence and success.
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